| Project/Area Number |
23792421
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Orthodontic/Pediatric dentistry
|
|---|
| Research Institution | Tokyo Medical and Dental University |
|---|
Principal Investigator |
WATARI IPPEI 東京医科歯科大学, 医歯(薬)学総合研究科, 助教 (10431941)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | GPCR class B / GLP-1 / GIP / 骨再生 / RNAサイレンシング / 唾液腺遺伝子治療 / GPCR / インクレチン / 骨芽細胞 / GPCR-B / 骨代謝 / 歯槽骨再生 / 耐糖能異常 / RNAi / non-coding RNA |
|---|
| Research Abstract |
The purpose of this project is to explore the possible implementation of GPCR-B signaling in a new treatment method for bone diseases using an in vitro approach. Incretin receptors, GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), belong to GPCR-B family and are suggested to play an important role in bone metabolism. The osteoblastic cell line, MC3T3-E1 was found to express both GIPR and GLP-1R. The quantitative PCR analysis showed that expression of both receptors was upregulated after stimulation with BMP-2. Determination of molecular mechanisms involved in regulation of bone metabolism by incretin receptors-related signaling will help to developed effective strategy for bone regeneration.
|
